Shares of Goldman Sachs were down 1.5 percent at $180.50 premarket as Chief Executive Lloyd Blankfein said he had a "highly curable" form of lymphoma.
chief_executive_officer: Goldman Sachs, Lloyd Blankfein; employer: Lloyd Blankfein, Goldman Sachs